ENZ Enzo Biochem: Rasio Kapitalisasi Pasar marang Nilai Buku

Simbol resmi perusahaan Enzo Biochem (ENZ)

Enzo Biochem, Inc. (ENZ) is implementing advanced molecular tests and DNA tagging to enhance diagnostic accuracy. This chart illustrates the price-to-book value multiple on the GURU.Markets platform, where the value of 0.35 expresses the metric level. Stable FCF and margins are driven by the sale of unique reagents. Management is currently restructuring its strategy, focusing on the monetization of intellectual property following a business model pivot.

enzo.com (ENZ): Rasio Kapitalisasi marang Nilai Buku saka 04.07.2022 nganti 26.04.2025
Barang utama Enzo Biochem, Inc.

To assess asset quality, an investor compares a business's market price to its book value. This ratio measures the premium or discount of the market valuation relative to net assets minus liabilities. By analyzing the trend of the market-to-book ratio, one can promptly track the company's revaluation. For Enzo Biochem, Inc. (ENZ), this indicator reflects the value of its intellectual property. The patent portfolio in DNA labeling creates a fundamental base that supports capitalization even amidst fierce competition.

Pesaing utama

A (Agilent Technologies) - Rasio Nilai Pasar marang Nilai Buku|questdiagnostics.com (DGX) - Rasio Kapitalisasi marang Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku ILMN (Illumina)|Koefisien Nilai Pasar marang Nilai Buku Exact Sciences Corp|Rasio Kapitalisasi Pasar marang Nilai Buku PerkinElmer RVTY|Rasio Kapitalisasi marang Nilai Buku Bio-Rad Corp (BIO)|Rasio Kapitalisasi Pasar marang Nilai Buku NNNN (Anbio Biotechnology)|soterahealth.com - Rasio Kapitalisasi Pasar marang Nilai Buku|QuidelOrtho Corporation (QDEL) - Rasio Nilai Pasar marang Nilai Buku|OPK - Rasio Kapitalisasi marang Nilai Buku|CDNA: Rasio Kapitalisasi Pasar marang Nilai Buku|MRVI (Maravai) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Fulgent Genetics, Inc.|Rasio Nilai Pasar marang Nilai Buku fluidigm.com (LAB)|Cytek Biosciences - Rasio Kapitalisasi marang Aset Bersih|Koefisien Nilai Pasar marang Nilai Buku OSUR (OraSure Technologies, Inc.)|Rasio Nilai Pasar marang Nilai Buku XGN|Kapitalisasi Pasar marang Nilai Buku MDxHealth, Inc. MDXH|Rasio Kapitalisasi Pasar marang Nilai Buku LUCD (Lucid Diagnostics Inc.)|PRE: Kapitalisasi Pasar marang Nilai Buku|imdxinc.com - Rasio Nilai Pasar marang Nilai Buku|Trinity Biotech (TRIB) - Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku PRPH (ProPhase)|Koefisien Nilai Pasar marang Nilai Buku AIMD|Rasio Nilai Pasar marang Nilai Buku Co-Diagnostics, Inc. CODX|Rasio Kapitalisasi marang Nilai Buku heartsciences.com HSCS|Biomerica (BMRA) - Rasio Kapitalisasi marang Aset Bersih|Cardio Diagnostics Holdings Inc. - Kapitalisasi Pasar marang Aset Bersih|VRAX (Virax Biolabs Group Ltd) - Rasio Nilai Pasar marang Nilai Buku|Bluejay Diagnostics Corp (BJDX) - Koefisien Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Aspira Women's Health AWH|acceleratediagnostics.com (AXDX) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku CENTOGENE N.V.|Rasio Nilai Pasar marang Nilai Buku Fresh2|GENE (Genetic Technologies) - Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku ME (23andMe Inc)|PMD: Rasio Nilai Pasar marang Nilai Buku